LEADER 03762nam  2200709Ia 450 
001 9910823645003321
005 20200520144314.0
010   $a1-107-16320-X
010   $a1-280-54139-3
010   $a9786610541393
010   $a0-511-22556-3
010   $a0-511-22613-6
010   $a0-511-22424-9
010   $a0-511-31774-3
010   $a0-511-48913-7
010   $a0-511-22491-5
035   $a(CKB)1000000000352813
035   $a(EBL)268222
035   $a(OCoLC)560236069
035   $a(SSID)ssj0000224080
035   $a(PQKBManifestationID)11200774
035   $a(PQKBTitleCode)TC0000224080
035   $a(PQKBWorkID)10205532
035   $a(PQKB)11130588
035   $a(UkCbUP)CR9780511489136
035   $a(MiAaPQ)EBC268222
035   $a(Au-PeEL)EBL268222
035   $a(CaPaEBR)ebr10131641
035   $a(CaONFJC)MIL54139
035   $a(PPN)183064976
035   $a(EXLCZ)991000000000352813
100   $a20040319d2004      uy         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe politics of personalised medicine $epharmacogenetics in the clinic /$fAdam Hedgecoe
205   $a1st ed.
210   $aCambridge, UK ;$aNew York $cCambridge University Press$d2004
215   $a1 online resource (vii, 208 pages) $cdigital, PDF file(s)
225 1 $aCambridge studies in society and the life sciences
300   $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
311   $a0-521-60265-3 
311   $a0-521-84177-1 
320   $aIncludes bibliographical references (p. 182-204) and index.
327   $aPersonalised medicine : a revolution in healthcare -- Pharacogenetics, expectation and promissory science -- Genetics, moral risk and professional resistance -- Clinical resistance to Alzheimer's pharmacogenetics -- Research, industry and pharamacogenetic literacy -- Engineering the clinic : getting personalised medicine into practice -- The fourth hurdle : cost-effectiveness and the funding of pharmacogenetics -- Disappointment and disclosure in the pharmacogenetic clinic -- The personalised is political.
330   $aPharmacogenetics, the use of genetic testing to prescribe and develop drugs, has been hailed as a revolutionary development for the pharmaceutical industry and modern medicine. Supporters of 'personalised medicine' claim the result will be safer, cheaper, more effective drugs, and their arguments are beginning to influence policy debates. Based on interviews with clinicians, researchers, regulators and company representatives, this book explores the impact of pharmacogenetics on clinical practice, following two cases of personalised medicine as they make their way from the laboratory to the clinic. It highlights the significant differences between the views of supporters of pharmacogenetics in industry and those who use the technology at the clinical 'coal face'. Theoretically, this work builds on the developing area of the sociology of socio-technical expectations, highlighting the way in which promoters of new technologies build expectations around it, through citation and the creation of technological visions.
410  0$aCambridge studies in society and the life sciences.
606   $aPharmacogenetics$xSocial aspects
606   $aPharmacology$xSocial aspects
615  0$aPharmacogenetics$xSocial aspects.
615  0$aPharmacology$xSocial aspects.
676   $a615.5/8
700   $aHedgecoe$b Adam$01641940
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910823645003321
996   $aThe politics of personalised medicine$93986367
997   $aUNINA